I am a Postdoctoral Research Scientist
at the Columbia University Irving Medical Center where I am understanding the
mechanism of AICDA, a DNA mutator with paramount importance in antibody
diversity in on target activity using human Bcells. I am studying this by
targeted degradation of essential proteins using a state of art technology
called Degron system which are generated using knockin and single cell cloning.
These targets were identified from mass spec and mutations seen in DHL and
DLBCL a form of Bcell lymphoma.
During my Ph.D I delineated interaction
between CD40L- CD40 during a macrophages T cell interaction using residue
specific functions on CD40L which are reported in hyper IgM syndrome. While
studying this I also generated avirulent strains of Leishmania parasites which
we testes as a vaccine strain in different knockout mice and studied the immune
response elicited by this vaccine. I also developed a DNA vaccine against one of
the target proteins in the Leishmania and testes it. During my master's in
Virology from the National Institute of Virology, Pune I study different
classes of virus and their pathogenesis. In particular, I studied the role of
host kinases in the pathogenesis of the Japanese Encephalitis virus for my
master's dissertation. I have a deep understanding of Immunology, APC-Tcell
interaction, host-pathogen interactions, RNA biology, Bcell biology and
vaccines. My area of interest is immunology, tumor immunology, macrophages,
Bcells, host-pathogen interactions, virology, RNA biology, and cancer biology.
Research Interest: Lymphoma, Bcell biology,
receptor-ligand interaction, host-pathogen-interaction, macrophages and tumor
immunity
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."